Borealis Biosciences, Inc. is seeking a Biomarker & Bioanalytical Development Lead to own the bioanalytical and biomarker strategy across the RNA therapeutics portfolio.
This senior scientist will design, build, and oversee assays measuring drug exposure, target engagement, pharmacodynamic response, and safety to support IND-enabling nonclinical and early clinical development. The role focuses on preparing for a Phase 1/2 trial, including development and transfer of regulated PK assays,
#J-18808-Ljbffr
Biomarker & Bioanalytical Strategy Lead, RNA Therapeutics in Vancouver employer: Borealis Biosciences, Inc.
Borealis Biosciences is an exceptional employer dedicated to advancing science and improving patient outcomes, particularly in the field of kidney diseases. With a strong emphasis on innovation, collaboration, and employee growth, we offer a dynamic work culture that values diversity and inclusion, alongside competitive benefits such as RRSP matching and wellness spending accounts for our Canadian employees. Located in Vancouver, BC, our state-of-the-art facilities provide a stimulating environment for professionals eager to make a meaningful impact in the biotechnology sector.
Contact Details:
Borealis Biosciences, Inc. Recruitment Team
